Quality of life in insect venom allergic patients

Current Opinion in Allergy and Clinical Immunology

Volumn 3, Issue 4, 2003, Pages 287-293

  Oude Elberink, Joanne N G ^a   Dubois, Anthony E J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Epipen; HRQL; Hymenoptera; Insect venom allergy; Quality of life; Venom immunotherapy

Indexed keywords

ADRENALIN; INSECT VENOM;

ANAPHYLAXIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HYMENOPTERA; IMMUNOTHERAPY; INSECT ALLERGY; INSECT STING; MORBIDITY; MORTALITY; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING;

ANAPHYLAXIS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYMENOPTERA; HYPERSENSITIVITY; INSECT BITES AND STINGS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0042009735     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200308000-00009     Document Type: Review

References (18)

1. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52:259-264.
2. Mosbech H. Deaths resulting from bee and wasp stings in Denmark 1960-1980 [in Danish]. Ugeskr Laeger 1983; 145:1757-1760.
3. Charpin D, Birnbaum J, Vervloet D. Epidemiology of hymenoptera allergy. Clin Exp Allergy 1994; 24:1010-1015.
4. Murphy EE, Slavin RG. Decreased incidence of stings in venom-sensitive patients following venom immunotherapy. Allergy Proc 1994; 15:57-59.
5. Muller UR. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart, New York: Gustav Fischer Verlag; 1990.
6. Rubenstein HS. Allergists who alarm the public. A problem in medical ethics. JAMA 1980; 243:793-794.
7. van der Linden PW, Struyvenberg A, Kraaijenhagen RJ, et al. Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med 1993; 118:161-168.
8. Confino-Cohen R, Melamed S, Goldberg A. Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy 1999; 29:1626-1631.
9. Oude Elberink JN, de Monchy JG, Golden DB, et al. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 2002; 109:162-170. This paper outlines the quality of life issues of Hymenoptera allergic patients and describes the development of the VQLQ, which is included as an appendix.
10. Hyland ME. The influence of beliefs on the quality of life of patients with allergic diseases. Clin Exp Allergy 1999; 29:1591-1592.
11. Oude Elberink JN, de Monchy JG, van der HS, et al. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002; 110:174-182. This was the first study examining HRQL in Hymenoptera allergic patients. The effect of VIT on HRQL was compared with the Epipen with an extensive discussion about the methodology. The paper also includes the complete patient information document which was used in the study.
12. Golden DB, Kwiterovich KA, Kagey-Sobotka A, et al. Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol 1996; 97:579-587.
13. Committee on Insects. The discontinuation of Hymenoptera venom immunotherapy. Report from the Committee on Insects. J Allergy Clin Immunol 1998; 101:573-575.
14. Portnoy JM, Moffitt JE, Golden DB, et al. Stinging insect hypersensitivity: a practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol 1999; 103:963-980.
15. European Academy of Allergology and Clinical Immunology. Position paper: Immunotherapy with hymenoptera venoms. The European Academy of Allergology and Clinical Immunology (EAACI). Allergy 1993; 48:36-46.
16. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials, J Allergy Clin Immunol 1994; 93:413-423.
17. Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996; 5:35-46.
18. McGain F, Harrison J, Winkel KD. Wasp sting mortality in Australia. Med J Aust 2000; 173:198-200.